packageBrinzolamide

brinzolamide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Brinzolamide is a carbonic anhydrase inhibitor used to treat glaucoma, especially open-angle glaucoma, and ocular hypertension. It is an approved eye medicine, authorised in the European Union for lowering pressure in the eye.

Summary written by glm-5.3-flash from Wikidata Q411517 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:brinzolamide
ATC codes:S01EC04
DrugBank:DB01194
PubChem CID:68844
ChEBI:3176
Wikidata:Q411517
formula:C12H21N3O5S3
molar mass:383.496 g/mol (PubChem CID 68844)
logP:-0.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown